Caris Life Sciences, Inc.

Healthcare · Biotechnology · —

27.10$ -1.3% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

Caris Life Sciences, Inc. (CAI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,230 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CAI
Line item	Q2 14	Q3 14	Q4 14	Q1 15	Q2 15	Q3 15	Q4 15	Q1 16	Q2 16	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	1,747	1,793	1,796	1,883	1,966	1,992	1,987	1,995	2,035	2,027	2,056	2,068	2,111	2,356	2,430	2,555	2,720	2,999	3,013	2,918	2,985	2,951	2,902	2,878	2,746	3,069	2,613	2,677	2,955	3,266	–	–	–	344	292	955	985	1,126	1,162	1,230
Current Assets	137	138	145	143	154	156	144	138	127	138	135	126	122	137	140	151	181	199	220	221	557	500	499	280	222	516	215	207	211	243	–	–	–	216	171	833	854	998	1,014	1,058
Cash	47	50	54	57	61	64	53	53	32	37	46	33	25	35	35	44	41	38	45	47	57	48	46	109	48	42	54	48	39	47	122	–	–	64	31	719	753	798	821	691
Cash & Short-Term Investments	63	50	72	76	81	84	74	74	56	69	66	53	49	63	65	79	95	113	121	122	132	115	46	109	48	118	133	48	39	47	122	–	–	66	33	721	755	800	823	793
Receivables	71	72	76	71	76	78	76	83	93	98	84	84	90	97	101	103	137	158	172	170	172	160	160	162	146	141	144	153	166	191	–	–	–	88	80	51	27	112	91	117
Inventory	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	40	37	41	49	64	76	124
Goodwill	–	–	–	–	–	2.9	2.9	9.0	15	16	16	16	16	16	16	16	16	16	16	16	16	16	16	16	–	–	–	–	–	–	–	–	–	19	19	19	19	19	19	19
Intangible Assets	0.5	0.4	0.3	0.2	0.1	1.3	1.2	4.8	11	10	9.7	9.0	8.6	8.2	7.7	7.2	6.6	6.2	5.7	5.3	4.9	4.5	4.1	3.7	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	1,323	1,366	1,353	1,423	1,492	1,516	1,525	1,531	1,569	1,568	1,598	1,603	1,631	1,858	1,867	1,932	2,092	2,303	2,311	2,214	2,293	2,265	2,209	2,188	2,058	2,370	1,910	1,950	2,199	2,466	20	–	–	621	2,891	502	506	548	569	638
Current Liabilities	293	267	249	305	283	192	218	167	153	169	164	172	215	356	260	328	375	487	426	408	425	407	287	263	297	629	320	279	467	338	–	–	–	165	163	90	86	127	144	191
Short-Term Debt	231	184	204	224	231	134	172	115	89	100	96	85	113	133	132	169	160	195	311	319	313	310	218	217	251	502	183	184	116	162	–	–	–	66	66	7.4	6.6	0.2	6.0	6.5
Accounts Payable	7.6	6.8	8.4	6.2	6.7	11	12	15	14	13	14	9.9	7.3	6.3	7.8	6.8	6.5	6.3	7.4	7.4	8.2	11	7.3	8.9	4.6	3.9	3.7	3.2	4.4	3.4	–	–	–	28	24	29	29	39	70	86
Long-Term Debt	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	317	374	376	378	381	393
Shareholders' Equity	424	427	442	459	473	475	460	463	466	459	458	465	480	499	564	623	629	696	701	704	692	686	693	690	687	699	702	726	756	801	-20	–	–	-277	-2,600	453	478	577	593	592
Retained Earnings	260	277	293	306	319	332	320	327	331	325	325	331	343	361	398	415	434	454	471	487	495	488	493	490	487	496	503	532	562	606	–	–	–	-2,472	-2,583	-2,655	-2,631	-2,549	-2,549	-2,550
Shares Outstanding	22	21	21	21	21	21	20	20	19	19	19	19	19	20	20	21	20	19	19	19	18	18	17	17	18	18	18	18	17	18	255	255	281	281	255	276	297	290	283	283

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings